GlassScriptPhysician profile
Sang K Kim
NPI 1336142579
$552.89
in general payments reported to CMS, 2019-2025
8 companies · $31.35 in 2025
The $31.35 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.62 · 2023: $126 · 2024: $325 · 2025: $31.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $297.07 | 2022-2024 | Ffrangio, Symplicity G3, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $73.88 | 2024 | |
| Janssen Pharmaceuticals, INC | $54.61 | 2023-2024 | Xarelto |
| Pfizer INC. | $31.35 | 2025 | |
| Teleflex LLC | $28.05 | 2024 | Guideliner |
| Shockwave Medical, INC | $27.44 | 2022 | |
| Siemens Medical Solutions USA, INC. | $24.32 | 2024 | Artis Icono Biplane |
| E.R. Squibb & Sons, L.L.C. | $16.17 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sang Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.